FCF yield společnosti Suda Pharmaceuticals Ltd
Jaká je hodnota metriky FCF yield společnosti Suda Pharmaceuticals Ltd?
Hodnota metriky FCF yield společnosti Suda Pharmaceuticals Ltd je -36.62%
Jaká je definice metriky FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield společností v sektoru Health Care sektor na ASX ve srovnání se společností Suda Pharmaceuticals Ltd
Čemu se věnuje společnost Suda Pharmaceuticals Ltd?
Suda Pharmaceuticals Ltd engages in the development of drug delivery technology in Australia, India, Europe and Korea. It offers ZolpiMist, an oro-mucosal spray formulation of zolpidem tartrate marketed under the brand name of Ambien or Stilnox, a non-benzodiazepine prescribed for the short-term treatment of insomnia. The company's product pipeline includes Sumatriptan, an oral spray formulation for the treatment of acute migraine; and anagrelide, a platelet lowering agent for use in thrombosis, which is used for the treatment of cancer. Suda Pharmaceuticals Ltd has license and supply agreement with Teva Pharmaceuticals International GmbH and Mitsubishi Tanabe Pharma Singapore for ZolpiMist oral spray; product development, licence, and supply agreement with Cann Pharmaceutical Australia Ltd for the development of novel oral spray of pharmaceutical-grade cannabinoid derivatives for the treatment of drug resistant epilepsy, melanoma, and motion sickness; and feasibility and option agreement with Zelira Therapeutics for the use of cannabinoids for a range of uses, including insomnia, autism, opioid reduction, anxiety, pain, and cancer. The company also has a feasibility study and option agreement with Laboratorios Ordesa, S.L. The company was formerly known as Suda Limited and changed its name to Suda Pharmaceuticals Ltd in November 2017. Suda Pharmaceuticals Ltd was incorporated in 1999 and is headquartered in Osborne Park, Australia.
Firmy s metrikou fcf yield podobnou společnosti Suda Pharmaceuticals Ltd
- Hodnota metriky FCF yield společnosti Home Capital je -36.76%
- Hodnota metriky FCF yield společnosti InflaRx N.V je -36.76%
- Hodnota metriky FCF yield společnosti Hanstone Gold je -36.67%
- Hodnota metriky FCF yield společnosti vTv Therapeutics Inc je -36.67%
- Hodnota metriky FCF yield společnosti Harbin Electric je -36.67%
- Hodnota metriky FCF yield společnosti The Crypto je -36.65%
- Hodnota metriky FCF yield společnosti Suda Pharmaceuticals Ltd je -36.62%
- Hodnota metriky FCF yield společnosti Montem Resources je -36.57%
- Hodnota metriky FCF yield společnosti Novacyt S.A je -36.55%
- Hodnota metriky FCF yield společnosti Jiulian Resources je -36.51%
- Hodnota metriky FCF yield společnosti Banco Bilbao Vizcaya Argentaria SA je -36.49%
- Hodnota metriky FCF yield společnosti DMG Blockchain Solutions je -36.49%
- Hodnota metriky FCF yield společnosti Virgin Galactic Inc je -36.45%